i have somewhat tepid expectations from the ROW deal as a short term upward catalyst. Apart from a modest upfront payment, ROW will be atleast 18 months from registration and revenue IMO. not to say it wont be profitable, but there is alot of work to engage and go through the red tape of each region, not to mention negotiation on price and conditions of approval.
If instos are looking at nnz2591 as the real star of neuren, i wouldn't be surprised if they supress the price on the ROW announcement so they can shake the market.
US is looking mega and the next real catalyst for me is whether 2591 shows some efficacy and how close have the mouse models been replicated? that for me is defining whether neu is a $10 stock or $80.
i have somewhat tepid expectations from the ROW deal as a short...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.42 |
Change
0.170(0.84%) |
Mkt cap ! $2.585B | |||
| Open | High | Low | Value | Volume |
| $20.40 | $20.50 | $20.25 | $566.7K | 27.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13 | $20.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.43 | 15 | 1 |
View Market Depth
| Last trade - 10.38am 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.28 |
Change
0.170 ( 0.23 %) |
||||
| Open | High | Low | Volume | ||
| $20.45 | $20.50 | $20.26 | 7613 | ||
| Last updated 10.58am 08/05/2024 ? | |||||
| NEU (ASX) Chart |